Reduced interleukin-8 production by cystic fibrosis airway epithelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 20, Issue 5, 1999, Pages 1073-1080

  Rene, A ^b   Massengale, D ^b   Quinn Jr , Francis ^b   Yankaskas, James ^b   Weissman, David ^b   McClellan, W Thomas ^b   Cuff, Christopher ^b   Aronoff, Stephen C ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

INTERLEUKIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ARTICLE; BIOSYNTHESIS; BRONCHUS; CELL LINE; CYSTIC FIBROSIS; CYTOLOGY; EPITHELIUM CELL; GENETICS; HOMOZYGOTE; HUMAN; METABOLISM; PATHOGENICITY; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRONCHI; CELL LINE, TRANSFORMED; CYSTIC FIBROSIS; EPITHELIAL CELLS; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0033128965     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.20.5.3243     Document Type: Article

References (32)

1. FitzSimmons, S. C. 1996. Cystic Fibrosis Foundation Patienl Registry 1095 Annual Report. Cystic Fibrosis Foundation, Bethesda, MD.
2. Denning, G. M., L. S. Ostedgaard, and M. J. Welsh. 1992. Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J. Cell. Biol. 118:551-559.
3. Kerem, B. S., J. M. Rummens, J. A. Buchanan, D. Markiewicz, T. K. Cox, A. Chakravarti, M. Buchwald, and L. C. Tsui. 1989. Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073-1078.
4. Thomassen, M., C. Demko, and O. Doershuk. 1987. Cystic fibrosis: a review of pulmonary infections and interventions. Pediatr. Pulmonol. 3:334-351.
5. Davis, P. 1993. Pathophysiology of the lung disease in cystic fibrosis. In Cystic Fibrosis. P. Davis, editor. Marcel Dekker, New York. 193-211.
6. Konstan, M. W., and M. Berger. 1993. Infection and inflammation of the lung in cystic fibrosis. In Cystic Fibrosis. P. Davis, editor. Marcel Dekker, New York. 291-276.
7. Bonfield, T. L., J. R. Panuska, M. W. Konstan, K. A. Hilliard, and M. Berger. 1995. Inflammatory cytokines in cystic fibrosis lungs. Am. J. Respir. Crit. Care Med. 152:2111-2118.
8. Noah, T., H. Black, P. Cheng, R. Wood, and M. Leigh. 1997. Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J. Infect. Dis. 175:638-647.
9. Konstan, M. W., K. A. Hilliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448-454.
10. Bonfield, T. L., M. Konstan, P. Burfeind, J. Panuska, J. Hilliard, and M. Berger. 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine IL-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 13:257-261.
11. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
12. Balough, K., M. McCubbin, M. Weinberger, W. Smits, R. Ahrens, and R. Fick. 1995. The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20:63-70.
13. Ruef, C., D. M. Jefferson, S. E. Schlegel-Hauster, and S. Suter. 1993. Regulation of cytokine secretion by cystic fibrosis airway epithelial cells. Eur. Respir. J. 6:1429-1436.
14. Nakamura, H., K. Yoshimura, H. A. Jaffe, and R. G. Crystal. 1991. Interleukin-8 expression in human bronchial epithelial cells. J. Biol. Chem. 266: 19611-19617.
15. Liu, L., F. P. J. Mul, T. W. Kuijpers, R. Lutter, D. Roos, and E. F. Knol. 1996. Neutrophil transmigration across monolayers of endothelial cells and airway epithelial cells is regulated by different mechanisms. Ann. NY Acad. Sci. 796:21-29.
16. Standiford, T. J. S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Tuews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line: a model for cytokine networks in the lung. J. Clin. Invest. 86:1945-1953.
17. Becker, S., H. Koren, and D. Henke. 1993. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am. J. Respir. Cell Mol. Biol. 8:20-27.
18. Moore, K., A. O'Garra, R. Malefyt, P. Vieira, and T. Mosmann. 1993. Interkeukin 10. Annu. Rev. Immunol. 11:165-190.
19. Moss, R., R. Bocian, Y. Hsu, Y. Dong, M. Kemna, T. Wei, and P. Gardner. 1996. Reduced IL-10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane regulator. Clin. Exp. Immunol. 106: 374-388.
20. Dean, T., Y. Dai, J. Shute, M. Church, and J. Warner. 1993. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis. Pediatr. Res. 34:159-161.
21. DiMango, E., H. Zar, R. Bryan, and A. Prince. 1995. Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8. J. Clin. Invest. 96:2204-2210.
22. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olson, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
23. Yankaskas, J. R., J. E. Haizlip, M. Conrad, D. Koval, E. Lazarowski, A. M. Paradiso, C. A. Rinehart, B. Sarkadi, R. Schlegel, and R. C. Boucher. 1993. Papilloma virus immortalized tracheal epithelial cells retain a well differentiated phenotype. Am. J. Physiol. 264:C1219-C1230.
24. Sarkadi, B., D. Bauzon, W. R. Huckle, H. S. Earp. A. Berry, H. Suchinddran, E. M. Price, J. C. Olson, R. C. Boucher, and G. A. Scaborough. 1992. Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells. J. Biol. Chem. 267:2087-2095.
25. Feinberg, A. P., and B. Vogelstein. 1984. A technique for radiolabelling DNA endonuclease restriction fragments to high specific activity (Addendum). Anal. Biochem. 137:266-267.
26. Landgraf, A., B. Reckmann, and A. Pingoud. 1991. Quantitative analysis of polymerase chain reaction (PCR) products using primers labeled with biolin and a fluorescent dye. Anal. Biochem. 193:231-235.
27. Church, G. M., and W. Gilbert. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81:1991-1995.
28. Smith, J. J., S. M. Travis, E. P. Greenberg, and M. J. Welsh. 1996. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85:229-236.
29. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, and J. M. Wilson. 1997. Human b-defensin-1 is a salt sensitive antibiotic in lung that is inactivaled in cystic fibrosis. Cell 88:553-560.
30. Armstrong, D. S., K. Grimwood, R. Carzino, and J. B. Carlin. 1995. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. Br. Med. J. 310:1571-1572.
31. Viallet, J., C. Liu, J. Emond, and M. S. Tsao. 1994. Characterization of human bronchial epithelial cells immortalized by the E6 and E7 genes of HPV type 16. Exp. Cell Res. 212:36-41.
32. Jetten, A. M., J. R. Yankaskas, M. J. Stutts, N. J. Willumsen, and R. C. Boucher. 1989. Persistence of abnormal chloride conductance regulation in transformed cystic fibrosis epithelia. Science 244:1472-1475.